Your browser doesn't support javascript.
loading
Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.
Kakkis, E D; McEntee, M F; Schmidtchen, A; Neufeld, E F; Ward, D A; Gompf, R E; Kania, S; Bedolla, C; Chien, S L; Shull, R M.
Afiliación
  • Kakkis ED; Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, California, 90502, USA.
Biochem Mol Med ; 58(2): 156-67, 1996 Aug.
Article en En | MEDLINE | ID: mdl-8812735
Enzyme replacement is a potential therapy for mucopolysaccharidosis I (MPS I), a lysosomal storage disorder caused by alpha-L-iduronidase deficiency. Previous work showed improvement in the tissues of MPS I dogs treated intravenously for 3 months with recombinant human alpha-L-iduronidase (25,000 units or approximately 0.1 mg/kg/week). We have now treated an MPS I-affected dog for 13 months to assess the clinical effects of enzyme replacement. The treated dog gained more weight, was more active, and had less joint stiffness than the untreated littermate. Biochemical and histologic studies demonstrated uptake of alpha-L-iduronidase and decreased lysosomal storage in the liver, kidney, spleen, lymph nodes, synovium, adrenals, and lungs. The brain had detectable enzyme activity and decreased glycosaminoglycan storage although histologic improvement was not evident. Cartilage and heart valve did not show any detectable improvement. A fivefold higher dose (approximately 0.5 mg/kg) administered five times over 10 days to two other dogs resulted in higher tissue enzyme activity and similarly decreased glycosaminoglycan storage and excretion. Antibodies to human alpha-L-iduronidase were induced in all treated dogs and may be associated with immune complex deposition and proteinuria. Recombinant canine alpha-L-iduronidase also induced antibody formation to a similar degree. The results support the conclusion that enzyme replacement is a promising therapy for MPS I though immunologic complications may occur.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mucopolisacaridosis I / Iduronidasa Límite: Animals / Female / Humans / Male Idioma: En Revista: Biochem Mol Med Asunto de la revista: BIOQUIMICA Año: 1996 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mucopolisacaridosis I / Iduronidasa Límite: Animals / Female / Humans / Male Idioma: En Revista: Biochem Mol Med Asunto de la revista: BIOQUIMICA Año: 1996 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos